Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▼ |
|---|---|---|---|
| 8THH | O60939 | Cryo-EM structure of Nav1.7 with LTG | |
| 8U66 | 8U66 | Firmicutes Rubisco | |
| 8WPG | P41180 | Human calcium-sensing receptor bound with cinacalcet in detergent | |
| 8WPU | P41180 | Human calcium-sensing receptor(CaSR) bound to cinacalcet in complex with Gq protein | |
| 8WPU | 8WPU | Human calcium-sensing receptor(CaSR) bound to cinacalcet in complex with Gq protein | |
| 8WPU | P41180 | Human calcium-sensing receptor(CaSR) bound to cinacalcet in complex with Gq protein | |
| 8WPU | 8WPU | Human calcium-sensing receptor(CaSR) bound to cinacalcet in complex with Gq protein | |
| 8WPU | P62873 | Human calcium-sensing receptor(CaSR) bound to cinacalcet in complex with Gq protein | |
| 8WPU | P59768 | Human calcium-sensing receptor(CaSR) bound to cinacalcet in complex with Gq protein | |
| 8IVP | A1TDP1 | Crystal structure of MV in complex with LLP and FRU from Mycobacterium vanbaalenii | |
| 8OPX | O53872 | Structure of Mycobacterium tuberculosis beta-oxidation trifunctional enzyme in complex with Trehalose (Fragment-B-TRE) | |
| 8OPX | O53871 | Structure of Mycobacterium tuberculosis beta-oxidation trifunctional enzyme in complex with Trehalose (Fragment-B-TRE) | |
| 8Q1K | Q8IV08 | Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5' exonuclease-mediated nucleic acid degradation | |
| 8Q1X | Q8IV08 | Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5' exonuclease-mediated nucleic acid degradation | |
| 8TUI | P43628 | Crystal structure of Fab-Lirilumab bound to KIR2DL3 | |
| 8TUI | 8TUI | Crystal structure of Fab-Lirilumab bound to KIR2DL3 | |
| 8TW3 | 8TW3 | hMPV fusion protein complexed with single domain antibodies sdHMPV16 and sdHMPV12 | |
| 8TW3 | H6X1Z0 | hMPV fusion protein complexed with single domain antibodies sdHMPV16 and sdHMPV12 | |
| 8U1G | P0DTC2 | Prefusion-stabilized SARS-CoV-2 S2 subunit | |
| 8WAA | P29401 | Human transketolase soaked with donor ketose D-xylulose | |
| 8WEJ | P13498 | Structure of human phagocyte NADPH oxidase in the activated state | |
| 8WEJ | P04839 | Structure of human phagocyte NADPH oxidase in the activated state | |
| 8WEJ | P14598 | Structure of human phagocyte NADPH oxidase in the activated state | |
| 8WEJ | A0A024R936 | Structure of human phagocyte NADPH oxidase in the activated state | |
| 8WEJ | A0A8C8XFZ1 | Structure of human phagocyte NADPH oxidase in the activated state | |
| 8WEJ | 8WEJ | Structure of human phagocyte NADPH oxidase in the activated state | |
| 8X2L | P13498 | Structure of human phagocyte NADPH oxidase in the resting state in the presence of 2 mM NADPH | |
| 8X2L | P04839 | Structure of human phagocyte NADPH oxidase in the resting state in the presence of 2 mM NADPH | |
| 8X2L | 8X2L | Structure of human phagocyte NADPH oxidase in the resting state in the presence of 2 mM NADPH | |
| 8XC4 | Q4VCP5 | Nipah virus attachment glycoprotein head domain in complex with a broadly neutralizing antibody 1E5 | |
| 8XC4 | 8XC4 | Nipah virus attachment glycoprotein head domain in complex with a broadly neutralizing antibody 1E5 | |
| 8CBD | 8CBD | SARS-CoV-2 Delta-RBD complexed with BA.4/5-1 and EY6A Fabs | |
| 8CBD | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with BA.4/5-1 and EY6A Fabs | |
| 8CBE | 8CBE | SARS-CoV-2 Delta-RBD complexed with BA.4/5-2 and Beta-49 Fabs | |
| 8CBE | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with BA.4/5-2 and Beta-49 Fabs | |
| 8CBF | 8CBF | SARS-CoV-2 Delta-RBD complexed with Omi-42 and Beta-49 Fabs | |
| 8CBF | P0DTC2 | SARS-CoV-2 Delta-RBD complexed with Omi-42 and Beta-49 Fabs | |
| 8CR5 | P43432 | Murine Interleukin-12 receptor beta 1 domain 1 in complex with murine Interleukin-12 beta. | |
| 8CR5 | Q60837 | Murine Interleukin-12 receptor beta 1 domain 1 in complex with murine Interleukin-12 beta. | |
| 8CR6 | P43432 | mouse Interleukin-12 | |
| 8CR6 | P43431 | mouse Interleukin-12 | |
| 8CR8 | P29460 | human Interleukin-23 | |
| 8CR8 | Q9NPF7 | human Interleukin-23 | |
| 8FYY | P09874 | Crystal structure of human PARP1 ART domain bound to inhibitor UKTT5 (compound 10) | |
| 8FYZ | P09874 | Crystal structure of human PARP1 ART domain bound to inhibitor UKTT10 (compound 13) | |
| 8FZ1 | P09874 | Crystal structure of human PARP1 ART domain bound to inhibitor UKTT22 (compound 14) | |
| 8I9B | P0DTC2 | S-ECD (Omicron BA.2.75) in complex with PD of ACE2 | |
| 8I9B | Q9BYF1 | S-ECD (Omicron BA.2.75) in complex with PD of ACE2 | |
| 8I9C | P0DTC2 | S-ECD (Omicron BF.7) in complex with PD of ACE2 | |
| 8I9C | Q9BYF1 | S-ECD (Omicron BF.7) in complex with PD of ACE2 |
